Seeking Alpha

William Haynes'  Instablog

William Haynes
Send Message
Academic, physician, technology orientated amateur investor.
  • Will the iPad add 0.2% at an annualized rate to US personal consumption in Q2? 0 comments
    May 19, 2010 12:56 PM | about stocks: AAPL
    This analysis makes some pretty bold assumptions but go with me:

    Apple sold 1 million ipads in the first month of sales. Assume that sales rate continues for the next 2 months (graduation gifts, 3G version, still hard to obtain), that makes 3 million in calendar Q2. Assume average revenue per ipad is $700 ($500 base price plus extra memory, 3G upgrade, accessories, itunes music/video/apps, ATT data plan). Total US sales likely exceed $2B in Q2. GDP per quarter is $3.6 trillion. Therefore, ipad sales could represent an additional 0.05% increment in personal consumption  (0.2% at the annualized headline rate). Of course, the impact of this increment in PCE on GDP will be offset by the import cost of ipads. The cost of production overseas probably 50% of the retail price, which would reduce the impact on GDP. Also, money spent on ipad sales may be taken from money consumers would have spent on other things (though anecdotally that does not seem to be happening). And, on the other hand, overseas sales of the ipad in Q2 will improve Apple's corporate income. 

    So (if my math is right!) the introduction of the ipad on April 3 has the potential to incrementally increase US GDP in Q2 by 0.2% at an annualized rate. 


    Disclosure: Long AAPL
    Stocks: AAPL
Back To William Haynes' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • FDA panel vote on proven unsafe drug Meridia (ABT) was split 8:8. This panel may be more sympathetic to lorcaserin (ARNA) than anticipated.
    Sep 15, 2010
  • Because obesity is probably the biggest contributor to cancer, ARNA could argue that weight loss from lorcaserin will reduce cancer.
    Sep 14, 2010
  • FDA lorcaserin (ARNA) review seems tough, but addressable. Animal cancer is the wild card. But Victoza got approved despite animal cancer.
    Sep 14, 2010
More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.